Osimertinib (AZD9291), a Mutant-Selective EGFR Inhibitor, Reverses ABCB1-Mediated Drug Resistance in Cancer CellsXiaoyu Zhang, Zhe‐Sheng Chen|Molecules|2016Cited by 48
Efficacy and safety of local glucocorticoids for the treatment of acute radiation-induced intestinal injury: protocol of a multicenter randomized controlled trialQianqian Li, Huishan Wang, Lichun Shao et al.|Frontiers in Pharmacology|2025Cited by 2